Metabolic network as an objective biomarker in monitoring deep brain stimulation for Parkinson’s disease: a longitudinal study

BACKGROUND: With the advance of subthalamic nucleus (STN) deep brain stimulation (DBS) in the treatment of Parkinson’s disease (PD), it is desired to identify objective criteria for the monitoring of the therapy outcome. This paper explores the feasibility of metabolic network derived from positron...

Descripción completa

Detalles Bibliográficos
Autores principales: Ge, Jingjie, Wang, Min, Lin, Wei, Wu, Ping, Guan, Yihui, Zhang, Huiwei, Huang, Zhemin, Yang, Likun, Zuo, Chuantao, Jiang, Jiehui, Rominger, Axel, Shi, Kuangyu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7596139/
https://www.ncbi.nlm.nih.gov/pubmed/33119814
http://dx.doi.org/10.1186/s13550-020-00722-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7596139/
https://www.ncbi.nlm.nih.gov/pubmed/33119814
http://dx.doi.org/10.1186/s13550-020-00722-1

Ejemplares similares